Fairvalue-Calculator Fairvalue-Calculator
EN DE

onesano S.A (ONO) Fair Value & Analysis

Basic Materials · PL · Market cap 41.5M PLN

Price0.5900 PLN
Fair Value0.2200 PLN
Upside-62.7%
Quality95/100
Evidence: Low Range 0.1700 PLN – 0.2800 PLN

Fair value as of: Jun 24, 2026

Analysis

onesano S.A (ONO) currently trades at 0.5900 PLN, while our model-based Fair Value estimate is 0.2200 PLN — implying the stock looks roughly 62.7% overvalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

onesano S.A. engages in the research and development in the areas of dietetics, animal nutrition, bioremediation, and agrotechnological processes in Poland. The company provides human dietary supplement products under the Estrovita brand. It also offers Yarrowia Equinox; Yarrowia Canifelox; and dietary supplements, functional foods, and cosmetic raw materials. It sells its products through chain pharmacies, pharmaceutical wholesalers, drugstores, e-commerce, veterinary offices, zoological and veterinary wholesalers, animal feed and supplementary mixture producers, and contract manufacturers. The company was formerly known as Skotan SA and changed its name to onesano S.A. in March 2023. onesano S.A. was founded in 1995 and is based in Chorzów, Poland.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is onesano S.A (ONO) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 0.2200 PLN versus a price of 0.5900 PLN — about −63% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ONO?
Our 21-model fair value for onesano S.A is 0.2200 PLN (as of Jun 24, 2026), built from audited fundamentals. The current price is 0.5900 PLN.
What is the quality score of ONO?
onesano S.A has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.